The effect of liraglutide on nonalcoholic fatty liver disease in type 2 diabetes mellitus

被引:0
|
作者
Xueyang Zhang
Ran Bai
Yong Jia
Junwei Zong
Yongbo Wang
Yanan Dong
机构
[1] The first affiliated Hospital of Dalian Medical University,Department of Endocrinology
[2] Dalian,Institute of Integrative Medicine
[3] Liaoning,Department of Orthopedics
[4] Dalian Medical University,undefined
[5] The first affiliated Hospital of Dalian Medical University,undefined
[6] Dalian,undefined
[7] Liaoning,undefined
来源
International Journal of Diabetes in Developing Countries | 2020年 / 40卷
关键词
Liraglutide; Nonalcoholic fatty liver disease; Type 2 diabetes;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:491 / 499
页数:8
相关论文
共 50 条
  • [31] Effect of nateglinide on nonalcoholic fatty liver disease as a complication in type 2 diabetes
    Matsuura, Kenichi
    Mori, Yutaka
    Itoh, Yohta
    Tajima, Naoko
    DIABETES, 2007, 56 : A555 - A555
  • [32] Therapeutic efficacy of liraglutide versus metformin in modulating the gut microbiota for treating type 2 diabetes mellitus complicated with nonalcoholic fatty liver disease
    Ying, Xing
    Zheng, Rongjiong
    Kahaer, Mayila
    Jiang, Chunhui
    Wulasihan, Muhuyati
    FRONTIERS IN MICROBIOLOGY, 2023, 14
  • [33] Nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus and its association with cardiovascular disease
    Vanjiappan, Sivabal
    Hamide, Abdoul
    Ananthakrishnan, Ramesh
    Periyasamy, Senthilkumar Gandhipuram
    Mehalingam, Vadivelan
    DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2018, 12 (04) : 479 - 482
  • [34] The aggravation of mitochondrial dysfunction in nonalcoholic fatty liver disease accompanied with type 2 diabetes mellitus
    Liu, Xiaolin
    Zhang, Jingyi
    Ming, Yanan
    Chen, Xiaoyu
    Zeng, Minde
    Mao, Yimin
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2015, 50 (09) : 1152 - 1159
  • [35] Cirrhosis Risk Prediction in individuals with Type 2 Diabetes Mellitus and Nonalcoholic Fatty Liver Disease
    Chun, Ji Sun
    Song, Yuri
    Lee, Woo Vin
    Ko, Minoh
    Jang, Ha Young
    Kim, In-Wha
    Kim, Hyunah
    Song, Yun-Kyoung
    Park, Sehoon
    Lee, Hajeong
    Lee, Hae-Young
    Kwak, Soo Heon
    Oh, Jung Mi
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 : 559 - 559
  • [36] Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
    Muhammad Adnan
    Abdul Wajid
    Wasif Noor
    Andleeb Batool
    Muhammad Aasim
    Kamran Abbas
    Quratul Ain
    Journal of Genetic Engineering and Biotechnology, 20
  • [37] Exploring Biomarkers in Nonalcoholic Fatty Liver Disease Among Individuals With Type 2 Diabetes Mellitus
    Ahmadizar, Fariba
    Younossi, Zobair M.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2025, 59 (01) : 36 - 46
  • [38] Interrelation of Nonalcoholic Fatty Liver Disease and Hemodynamic Values in Type 2 Diabetes Mellitus Patients
    Chernyaeva, Anna
    Kravchun, Nonna
    Zemlyanitsyna, Olga
    Chernyavskaya, Iryna
    Dorosh, Helen
    Romanova, Iryna
    Polozova, Lubov
    Dunayeva, Inna
    Karachentsev, Iurii
    DIABETES, 2016, 65 : A121 - A121
  • [39] Sociodemographic and genetic determinants of nonalcoholic fatty liver disease in type 2 diabetes mellitus patients
    Adnan, Muhammad
    Wajid, Abdul
    Noor, Wasif
    Batool, Andleeb
    Aasim, Muhammad
    Abbas, Kamran
    Ain, Quratul
    JOURNAL OF GENETIC ENGINEERING AND BIOTECHNOLOGY, 2022, 20 (01)
  • [40] Type 2 Diabetes Mellitus and Obesity Amplifies Nonalcoholic Fatty Liver Disease Risk with Age
    Sharma, Anu
    Leiva, Eddison Godinez
    Lomonaco, Romina
    Saenz, Enrique Valdez
    Rocha, Andrea Ortiz
    Gonzalez, Maria A.
    Marangi, Stephen A.
    Shrestha, Sulav
    Shetty, Shwetha S.
    Budd, Jeffrey T.
    Kalavalapalli, Srilaxmi
    Barb, Diana
    Cusi, Kenneth
    DIABETES, 2023, 72